87 related articles for article (PubMed ID: 12517589)
1. Gonadotropin releasing hormone analogue therapy alters signal transduction pathways involving mitogen-activated protein and focal adhesion kinases in leiomyoma.
Chegini N; Kornberg L
J Soc Gynecol Investig; 2003 Jan; 10(1):21-6. PubMed ID: 12517589
[TBL] [Abstract][Full Text] [Related]
2. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species increased focal adhesion kinase production in pulmonary microvascular endothelial cells.
Yang S; Yip R; Polena S; Sharma M; Rao S; Griciene P; Gintautas J; Jerome H
Proc West Pharmacol Soc; 2004; 47():54-6. PubMed ID: 15633612
[TBL] [Abstract][Full Text] [Related]
4. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells.
Ding L; Xu J; Luo X; Chegini N
J Clin Endocrinol Metab; 2004 Nov; 89(11):5549-57. PubMed ID: 15531510
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of hepatocyte growth factor-mediated vascular smooth muscle cell migration.
Ma H; Calderon TM; Kessel T; Ashton AW; Berman JW
Circ Res; 2003 Nov; 93(11):1066-73. PubMed ID: 14576199
[TBL] [Abstract][Full Text] [Related]
7. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Luo X; Ding L; Ripley D
Mol Cell Endocrinol; 2003 Nov; 209(1-2):9-16. PubMed ID: 14604812
[TBL] [Abstract][Full Text] [Related]
8. Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus.
Karanian DA; Brown QB; Makriyannis A; Bahr BA
Eur J Pharmacol; 2005 Jan; 508(1-3):47-56. PubMed ID: 15680253
[TBL] [Abstract][Full Text] [Related]
9. [FAK antisense oligodeoxynucleotides inhibit vascular smooth muscle cell migration and adhesion mediated by FAK-ERK1/2 signaling pathway].
Yin H; Wang LH; Huo Y; Peng X; Xia CF; Tang CS
Yao Xue Xue Bao; 2002 May; 37(5):334-8. PubMed ID: 12579835
[TBL] [Abstract][Full Text] [Related]
10. High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.
Schmitz KJ; Grabellus F; Callies R; Otterbach F; Wohlschlaeger J; Levkau B; Kimmig R; Schmid KW; Baba HA
Breast Cancer Res; 2005; 7(2):R194-203. PubMed ID: 15743500
[TBL] [Abstract][Full Text] [Related]
11. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy.
Luo X; Ding L; Xu J; Williams RS; Chegini N
Endocrinology; 2005 Mar; 146(3):1074-96. PubMed ID: 15604208
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.
Chegini N; Verala J; Luo X; Xu J; Williams RS
J Soc Gynecol Investig; 2003 Apr; 10(3):161-71. PubMed ID: 12699880
[TBL] [Abstract][Full Text] [Related]
13. Gonadotropin-releasing hormone and TGF-beta activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells.
Luo X; Ding L; Chegini N
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E991-E1001. PubMed ID: 15265761
[TBL] [Abstract][Full Text] [Related]
14. Soluble collagen VI induces tyrosine phosphorylation of paxillin and focal adhesion kinase and activates the MAP kinase erk2 in fibroblasts.
Rühl M; Johannsen M; Atkinson J; Manski D; Sahin E; Somasundaram R; Riecken EO; Schuppan D
Exp Cell Res; 1999 Aug; 250(2):548-57. PubMed ID: 10413607
[TBL] [Abstract][Full Text] [Related]
15. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
[TBL] [Abstract][Full Text] [Related]
16. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Yun BS; Seong SJ; Cha DH; Kim JY; Kim ML; Shim JY; Park JE
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():62-7. PubMed ID: 26093349
[TBL] [Abstract][Full Text] [Related]
17. Enterocytic differentiation of the human Caco-2 cell line correlates with alterations in integrin signaling.
Lévy P; Robin H; Kornprobst M; Capeau J; Cherqui G
J Cell Physiol; 1998 Dec; 177(4):618-27. PubMed ID: 10092214
[TBL] [Abstract][Full Text] [Related]
18. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy.
Khan KN; Kitajima M; Hiraki K; Fujishita A; Sekine I; Ishimaru T; Masuzaki H
Hum Reprod; 2010 Mar; 25(3):642-53. PubMed ID: 20008888
[TBL] [Abstract][Full Text] [Related]
19. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells.
Hauck CR; Sieg DJ; Hsia DA; Loftus JC; Gaarde WA; Monia BP; Schlaepfer DD
Cancer Res; 2001 Oct; 61(19):7079-90. PubMed ID: 11585739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
